Main Street Financial Solutions, LLC Outlook Therapeutics, Inc. Transaction History

Main Street Financial Solutions, LLC

  • $1.11 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023
BUY
$0.2 - $1.78 $7,000 - $62,300
35,000 Added 140.0%
60,000 $13,000
Q2 2023

Aug 04, 2023
BUY
$1.02 - $1.89 $25,500 - $47,250
25,000 New
25,000 $43,000

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $536M
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Main Street Financial Solutions, LLC Portfolio

Follow Main Street Financial Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Financial Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Financial Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email